Centre for Commercialization of Regenerative Medicine Australia
An Australian hub of Canada's Commercialization Centre for Regenerative Medicine (CCRM) will support the development of foundational technologies to accelerate the commercialisation of regenerative medicine products and therapies.
CCRM Australia will be modelled on, and linked with, the highly successful Centre for Commercialization of Regenerative Medicine (CCRM) based in Canada, a leader in developing and commercialising regenerative medicine and cell and gene technologies. Drawing from CCRM's expertise and industry and capital venture networks established over a five-year period, CCRM Australia will take a leading role in supporting Australia's fast developing regenerative medicine sector. It will take a national approach to the commercialization of Australian regenerative medicine and related technologies. CCRM Australia will be developed in parallel with other emerging hubs in the United States, Israel, Japan, Europe and Singapore.
Outcomes: During the project ten regenerative medicine product companies started collaborating internationally and five collaboration events were held with over 500 attendees.
| State | Victoria |
| Consortium lead | Monash University |
| Consortium members | CSIRO, CCRM Canada, Cell Therapies, St Vincent's Institute of Medical Research, AusBiotech Ltd |
| MTPConnect grant | $200,000 |
| Industry contribution | $358,382 |
| State Government Contribution | $150,000 |
| Project duration | March 2017 - February 2019 (Finished) |
| Contact | Silvio Tiziani, Monash University - silvio.tiziani@monash.edu +61 418 536 209 |
Visit CCRM Australia for more details | Twitter: ccrm_au | LinkedIn: CCRM Australia
Listen to our podcast episode on CCRM Australia, where MTPConnect spoke to its CEO Silvio Tziani.